Clinical Trial Update: Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This update notes that the Phase 2 clinical trial evaluating arsenic trioxide for women with locally advanced or metastatic breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN